tiprankstipranks
Trending News
More News >
Avient (AVNT)
NYSE:AVNT
Advertisement

Avient (AVNT) AI Stock Analysis

Compare
273 Followers

Top Page

AVNT

Avient

(NYSE:AVNT)

Rating:70Neutral
Price Target:
$39.00
â–²(8.33% Upside)
Avient's overall stock score reflects stable financial performance and positive corporate developments, such as the new credit facility. However, technical indicators suggest caution due to potential overbought conditions, and valuation metrics indicate the stock may be overvalued. The earnings call provided a balanced view with positive growth and debt reduction efforts, offset by challenges in consumer markets.
Positive Factors
Debt Management
AVNT plans to pay down $100-200 million of debt by year-end due to strong expected free cash flow.
Financial Performance
2Q sales and segment operating income were modestly above both MSe and consensus, with lower than expected corporate expense supporting the operating income beat.
Market Growth
Growth in healthcare and defense markets is expected to help offset declines in larger markets for AVNT.
Negative Factors
Consumer Demand
Weak consumer demand is a significant headwind, posing a downside risk to AVNT's guidance.
Economic Environment
Negative impacts include policy uncertainty, inflation and global slowdown, supply chain impacts from global trade policies and foreign exchange.
Market Demand
Lower demand into packaging and consumer end markets is weighing on growth expectations for the Color, Additives and Inks segment.

Avient (AVNT) vs. SPDR S&P 500 ETF (SPY)

Avient Business Overview & Revenue Model

Company DescriptionAvient Corporation provides specialized formulator, services, and sustainable material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. It operates through three segments: Color, Additives and Inks; Specialty Engineered Materials; and Distribution. The Color, Additives and Inks segment offers specialized color and additive concentrates in solid and liquid form for thermoplastics; dispersions for thermosets; and specialty inks. This segment products are used in various markets include medical, pharmaceutical devices, food packaging, personal care, cosmetics, transportation, building products, recreational, athletic apparel, construction, filtration, outdoor furniture, healthcare, wire, and cable. The Specialty Engineered Materials segment provides specialty polymer formulations, services, and solutions for designers, assemblers, and processors of thermoplastic materials; and long glass and carbon fiber technology to thermoset and thermoplastic composites. The Distribution segment distributes approximately 4,000 grades of engineering and commodity grade resins to custom injection molders and extruders. The company sells its products through direct sales personnel, distributors, and commissioned sales agents. The company was formerly known as PolyOne Corporation and changed its name to Avient Corporation in June 2020. Avient Corporation was founded in 1885 and is headquartered in Avon Lake, Ohio.
How the Company Makes MoneyAvient generates revenue through the sale of its specialty polymer products and services across various industries. The company has a diverse revenue model that includes direct sales to manufacturers and distributors, along with custom solutions tailored to specific customer needs. Key revenue streams include the sale of engineered materials, color and additive systems, and specialty inks. Avient also benefits from strategic partnerships with other companies in its supply chain, which enhance its product offerings and market reach. Additionally, the company's focus on sustainable solutions and innovation contributes to its ability to capture new market opportunities and maintain competitive pricing, further driving its earnings.

Avient Earnings Call Summary

Earnings Call Date:Aug 01, 2025
(Q2-2025)
|
% Change Since: 14.03%|
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Neutral
The earnings call presented a balanced view with notable achievements in organic growth, debt reduction, and innovation offset by challenges in consumer markets and raw material cost pressures. Strong demand in defense and health care provided a positive counterbalance to some regional and market-specific weaknesses.
Q2-2025 Updates
Positive Updates
Second Quarter Organic Sales Growth
Reported a 0.6% organic sales growth in the second quarter despite an uncertain macro environment.
Adjusted EPS and EBITDA Margin Expansion
Adjusted EPS grew 5% to $0.80, slightly ahead of guidance, with adjusted EBITDA margins expanding by 30 basis points to 17.2%.
Strong Performance in Defense and Health Care
Defense and health care sectors showed strong demand, with health care growing double digits.
Debt Reduction Achievements
Paid down $50 million of debt during the quarter, with plans to reduce total debt by $100 million to $200 million by year-end.
Patent Filings and Innovation
Patent filings increased by 50% in 2024 versus 2023, with expectations to exceed year-over-year filings again in 2025.
Negative Updates
Weak Performance in Consumer Markets
Consumer markets showed weakness globally, particularly impacting the U.S. and Canada, with consumer sales down 8% in Q2.
Challenges in EMEA
EMEA sales were down slightly, with packaging sales not experiencing the typical second-quarter seasonal benefit.
Impact of Planned Maintenance
Planned maintenance in the Avient Protective Materials business led to a $3 million impact on SEM's EBITDA for the quarter.
Pressure from Raw Material Costs
Experiencing low to mid-single-digit price increases in pigments and flame retardants, with some materials seeing more than 3x price increases due to supply constraints.
Company Guidance
In the call, Avient Corporation provided guidance indicating a stable but cautious outlook for the rest of 2025. The company reported a 0.6% organic sales growth in Q2, with adjusted EPS increasing by 5% to $0.80, slightly beating the guidance of $0.79. Adjusted EBITDA margins expanded by 30 basis points to 17.2%, driven by a favorable mix and productivity initiatives. For the full year, adjusted EBITDA is projected to be between $545 million and $560 million, and adjusted EPS is expected to range from $2.77 to $2.87. Avient is focused on realizing $40 million in benefits for 2025 from sourcing, Lean Six Sigma initiatives, and discretionary spending control, with $17 million already achieved in the first half. The company is also on track to reduce debt by $100 million to $200 million by year-end, having already repaid $50 million in Q2. Despite an uncertain macro environment, Avient sees strong demand in defense and health care sectors, which offsets weaknesses in consumer markets.

Avient Financial Statement Overview

Summary
Avient shows solid financial health with stable revenue and strong cash flow generation. However, declining profit margins and ROE suggest pressure on profitability, which requires attention to improve investor confidence.
Income Statement
75
Positive
Avient's income statement reflects stable revenue generation with a TTM (Trailing-Twelve-Months) revenue of $3.24 billion, slightly down from the previous year's $3.39 billion. The Gross Profit Margin for the TTM period stands at 32.18%, indicating strong product pricing and cost control. However, the Net Profit Margin decreased to 3.08% in the TTM period from 5.23% in the previous year, driven by lower EBIT and EBITDA margins, highlighting pressure on operating efficiencies and profitability.
Balance Sheet
70
Positive
Avient's balance sheet shows a moderate Debt-to-Equity Ratio of 0.90, reflecting a manageable level of leverage. The Equity Ratio stands at 39.55%, indicating a solid equity base relative to total assets. However, Return on Equity (ROE) has declined to 4.34% in the TTM period, indicating reduced profitability relative to shareholder equity, which may concern investors seeking strong returns.
Cash Flow
78
Positive
Avient's cash flow statement reveals robust cash generation capabilities, with an Operating Cash Flow to Net Income Ratio of 2.49 for the TTM, suggesting efficient conversion of income to cash. The Free Cash Flow to Net Income Ratio of 1.39 further supports solid cash flow health. While Free Cash Flow growth is slightly positive, the company must focus on sustaining this momentum amid fluctuating net income levels.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.25B3.24B3.14B3.40B4.82B3.24B
Gross Profit1.06B1.06B902.70M882.70M1.10B784.30M
EBITDA226.60M510.10M391.40M427.20M472.90M352.90M
Net Income118.90M169.50M75.70M83.10M230.80M131.60M
Balance Sheet
Total Assets6.13B5.81B5.97B6.08B5.00B4.87B
Cash, Cash Equivalents and Short-Term Investments474.50M544.50M545.80M641.10M601.20M649.50M
Total Debt2.02B2.15B2.14B2.24B1.93B1.95B
Total Liabilities3.76B3.48B3.63B3.73B3.21B3.17B
Stockholders Equity2.37B2.33B2.32B2.33B1.77B1.68B
Cash Flow
Free Cash Flow149.80M134.90M82.20M292.90M133.20M157.90M
Operating Cash Flow255.40M256.80M201.60M398.40M233.80M221.60M
Investing Cash Flow-105.60M-120.60M-94.20M-504.00M-150.20M-1.43B
Financing Cash Flow-172.50M-120.90M-201.70M166.40M-114.60M982.00M

Avient Technical Analysis

Technical Analysis Sentiment
Positive
Last Price36.00
Price Trends
50DMA
33.97
Positive
100DMA
34.27
Positive
200DMA
38.97
Negative
Market Momentum
MACD
0.52
Negative
RSI
61.07
Neutral
STOCH
85.15
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVNT, the sentiment is Positive. The current price of 36 is above the 20-day moving average (MA) of 33.97, above the 50-day MA of 33.97, and below the 200-day MA of 38.97, indicating a neutral trend. The MACD of 0.52 indicates Negative momentum. The RSI at 61.07 is Neutral, neither overbought nor oversold. The STOCH value of 85.15 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVNT.

Avient Risk Analysis

Avient disclosed 14 risk factors in its most recent earnings report. Avient reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Avient Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$3.62B42.7518.69%0.42%9.51%5.20%
70
Outperform
$3.18B32.035.62%1.52%-0.09%-37.60%
70
Neutral
$3.25B27.445.09%2.97%3.28%1.69%
70
Neutral
$4.93B36.6112.18%1.44%4.95%53.63%
61
Neutral
$2.06B110.001.55%1.96%-5.45%-87.13%
61
Neutral
$10.03B6.440.67%3.02%2.97%-45.32%
58
Neutral
$2.44B41.89-0.69%3.76%1.49%-105.20%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVNT
Avient
36.00
-9.55
-20.97%
FUL
H.B. Fuller Company
59.99
-20.28
-25.26%
HWKN
Hawkins
170.81
48.03
39.12%
IOSP
Innospec
84.17
-25.72
-23.41%
OLN
Olin
21.29
-21.19
-49.88%
SXT
Sensient Technologies
113.83
40.92
56.12%

Avient Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Avient Secures New $500M Revolving Credit Facility
Positive
Jun 16, 2025

On June 12, 2025, Avient Corporation entered into a new Revolving Credit Agreement with JPMorgan Chase Bank, replacing its previous credit agreement from 2019. This agreement introduces a senior secured revolving credit facility of up to $500 million, which can be increased by $250 million, and is intended for working capital, capital expenditures, and other corporate purposes. The facility allows for borrowings in U.S. Dollars and specified alternative currencies, with interest rates determined by Avient’s Consolidated Leverage Ratio. This financial move is expected to provide Avient with enhanced financial flexibility and support its operational and strategic initiatives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025